PAR PHARM Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PAR PHARM, and what generic alternatives to PAR PHARM drugs are available?
PAR PHARM has seventy-six approved drugs.
There is one US patent protecting PAR PHARM drugs. There are thirteen tentative approvals on PAR PHARM drugs.
There are nine patent family members on PAR PHARM drugs in eight countries and twenty-one supplementary protection certificates in eight countries.
Summary for PAR PHARM
International Patents: | 9 |
US Patents: | 1 |
Tradenames: | 37 |
Ingredients: | 37 |
NDAs: | 76 |
Patent Litigation for PAR PHARM: | See patent lawsuits for PAR PHARM |
PTAB Cases with PAR PHARM as petitioner: | See PTAB cases with PAR PHARM as petitioner |
Drugs and US Patents for PAR PHARM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Par Pharm | FENTANYL CITRATE | fentanyl citrate | TROCHE/LOZENGE;TRANSMUCOSAL | 077312-004 | Oct 30, 2009 | DISCN | No | No | ⤷ Subscribe | ||||||
Par Pharm | LEUCOVORIN CALCIUM | leucovorin calcium | TABLET;ORAL | 071598-001 | Oct 14, 1987 | DISCN | No | No | ⤷ Subscribe | ||||||
Par Pharm | METHOCARBAMOL AND ASPIRIN | aspirin; methocarbamol | TABLET;ORAL | 089657-001 | Nov 4, 1988 | DISCN | No | No | ⤷ Subscribe | ||||||
Par Pharm | OXYMORPHONE HYDROCHLORIDE | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200792-001 | Oct 24, 2014 | DISCN | No | No | ⤷ Subscribe | ||||||
Par Pharm | THIORIDAZINE HYDROCHLORIDE | thioridazine hydrochloride | TABLET;ORAL | 088352-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Subscribe | ||||||
Par Pharm | THIORIDAZINE HYDROCHLORIDE | thioridazine hydrochloride | TABLET;ORAL | 088480-001 | Dec 29, 1983 | DISCN | No | No | ⤷ Subscribe | ||||||
Par Pharm | THIORIDAZINE HYDROCHLORIDE | thioridazine hydrochloride | TABLET;ORAL | 089765-001 | Feb 9, 1988 | DISCN | No | No | ⤷ Subscribe | ||||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. |
International Patents for PAR PHARM Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2605413 | ⤷ Subscribe |
China | 101163679 | ⤷ Subscribe |
European Patent Office | 1948613 | ⤷ Subscribe |
Japan | 5378788 | ⤷ Subscribe |
Japan | 2008538560 | ⤷ Subscribe |
Mexico | 2007013118 | ⤷ Subscribe |
World Intellectual Property Organization (WIPO) | 2006115626 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for PAR PHARM Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1635783 | 122014000024 | Germany | ⤷ Subscribe | PRODUCT NAME: FENTANYL IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100831 |
0480717 | 98C0025 | Belgium | ⤷ Subscribe | PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215 |
0454511 | 99C0009 | Belgium | ⤷ Subscribe | PRODUCT NAME: IRBESARTAN / HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/98/086/001 19981015 |
0443983 | C00443983/03 | Switzerland | ⤷ Subscribe | PRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009 |
0901368 | C300523 | Netherlands | ⤷ Subscribe | PRODUCT NAME: FENTANYL; REGISTRATION NO/DATE: EU/2/11/127/001 20111006 |
1635783 | CA 2014 00016 | Denmark | ⤷ Subscribe | PRODUCT NAME: FENTANYL I EN HVILKEN SOM HELST AF DE FORMER, DER ER BESKYTTET AF GRUNDPATENTET; REG. NO/DATE: EU/1/10/644/001-006 20100831 |
0836511 | SPC/GB06/022 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: FENTANYL HYDROCHLORIDE; REGISTERED: UK EU/1/05/326/001 20060124 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.